Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Hypoxia-activated_prodrugs> ?p ?o }
Showing triples 1 to 34 of
34
with 100 triples per page.
- Hypoxia-activated_prodrugs abstract "Hypoxia-Activated Prodrugs (HAPs) are prodrugs that target regions of tumor hypoxia within tumor cells. HAPs may offer the potential, alone and in combination with conventional chemotherapy, of improving cancer therapy. It is believed that tumor hypoxia contributes significantly to treatment failure and relapse among cancer patients because cells in the hypoxic zones of solid tumors resist traditional chemotherapy for at least two reasons: first, most antitumor agents cannot penetrate beyond 50-100 micrometers from capillaries, thereby never reaching those cells in the hypoxic regions. Secondly, the lower nutrient and oxygen supply to cells in the hypoxic zones of tumors cause them to divide more slowly than their well oxygenated counterparts, so hypoxic tumor cells exhibit greater resistance to chemotherapies and radiation which target rapidly dividing cells or require oxygen for efficacy.Hypoxia also contributes to the invasive and metastatic phenotypes of aggressive cancers by promoting genetic instability and accelerating the accumulation of mutations that can ultimately give rise to drug resistance.There are several companies developing HAPs: Novacea, Inc., Proacta Inc. and Threshold Pharmaceuticals, Inc. These companies are developing the following drug candidates: AQ4N (Novacea), PR-104 (Proacta) and TH-302 (Threshold Pharmaceuticals).".
- Hypoxia-activated_prodrugs wikiPageID "18216135".
- Hypoxia-activated_prodrugs wikiPageLength "1905".
- Hypoxia-activated_prodrugs wikiPageOutDegree "8".
- Hypoxia-activated_prodrugs wikiPageRevisionID "630128599".
- Hypoxia-activated_prodrugs wikiPageWikiLink AQ4N.
- Hypoxia-activated_prodrugs wikiPageWikiLink Category:Experimental_cancer_drugs.
- Hypoxia-activated_prodrugs wikiPageWikiLink Category:Oxygen.
- Hypoxia-activated_prodrugs wikiPageWikiLink Evofosfamide.
- Hypoxia-activated_prodrugs wikiPageWikiLink PR-104.
- Hypoxia-activated_prodrugs wikiPageWikiLink Phenotype.
- Hypoxia-activated_prodrugs wikiPageWikiLink Phenotypes.
- Hypoxia-activated_prodrugs wikiPageWikiLink Prodrug.
- Hypoxia-activated_prodrugs wikiPageWikiLink TH-302.
- Hypoxia-activated_prodrugs wikiPageWikiLink Tumor_hypoxia.
- Hypoxia-activated_prodrugs wikiPageWikiLinkText "Hypoxia-activated prodrugs".
- Hypoxia-activated_prodrugs wikiPageWikiLinkText "hypoxia-activated prodrug".
- Hypoxia-activated_prodrugs wikiPageWikiLinkText "hypoxia-activated prodrugs".
- Hypoxia-activated_prodrugs hasPhotoCollection Hypoxia-activated_prodrugs.
- Hypoxia-activated_prodrugs wikiPageUsesTemplate Template:Biology-stub.
- Hypoxia-activated_prodrugs wikiPageUsesTemplate Template:Reflist.
- Hypoxia-activated_prodrugs subject Category:Experimental_cancer_drugs.
- Hypoxia-activated_prodrugs subject Category:Oxygen.
- Hypoxia-activated_prodrugs hypernym Prodrugs.
- Hypoxia-activated_prodrugs type Drug.
- Hypoxia-activated_prodrugs type Drug.
- Hypoxia-activated_prodrugs type Element.
- Hypoxia-activated_prodrugs comment "Hypoxia-Activated Prodrugs (HAPs) are prodrugs that target regions of tumor hypoxia within tumor cells. HAPs may offer the potential, alone and in combination with conventional chemotherapy, of improving cancer therapy.".
- Hypoxia-activated_prodrugs label "Hypoxia-activated prodrugs".
- Hypoxia-activated_prodrugs sameAs m.04cqs78.
- Hypoxia-activated_prodrugs sameAs Q5961513.
- Hypoxia-activated_prodrugs sameAs Q5961513.
- Hypoxia-activated_prodrugs wasDerivedFrom Hypoxia-activated_prodrugs?oldid=630128599.
- Hypoxia-activated_prodrugs isPrimaryTopicOf Hypoxia-activated_prodrugs.